Researchers from the University of Eastern Finland, Aalto University and the University of Oulu have developed a new ...

A CRISPR/Cas9-based galactose screening identifies key mitochondrial genes involved in OXPHOS and oxidative metabolism, ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

In the vast territories of the genome, Creative Biolabs uses CRISPR gene-editing technologies to rewrite the rules of genetic research and therapy development. SHIRLEY, NY, UNITED STATES, April 24, ...

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

A new set of genes that contribute to Parkinson’s disease risk has been identified.

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Ethical Dilemma And Legal Roadblocks. Legal News and Analysis - India - Regulatory & Compliance, Telecommunications, Media & Technology - Conventus Law ...

The best Samsung Galaxy S25 Ultra screen protectors feature first-rate touch sensitivity, durability, and a kit or tool for seamless application. To help you choose the right option, we've ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR ...